Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00907257 · ClinicalTrials.gov registry record · Phase 4
A Study of Different Use Regimens Using Two Acne Treatments
A Phase 4 study, sponsored by Bausch Health Americas.
- Completed
- Registry status
- Phase 4
- Development phase
- 247
- Enrollment target
NCT00907257 is a Phase 4 study that has completed, run by Bausch Health Americas. The registered enrollment target is 247 participants.
The verdict
NCT00907257, a Phase 4 study, has completed, sponsored by Bausch Health Americas.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 247 participants
- Enrollment target
Study Summary
A study to determine if using 2 acne products in the morning is as safe and efficacious as using one product in the morning and one product in the evening.
Interventions
- DRUG Tretinoin gel
- DRUG benzoyl peroxide wash
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 247 participants |
| Start Date | 2009-02 |
| Est. Completion | 2009-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00907257
The ClinicalTrials.gov registry entry for NCT00907257 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 247 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch Health Americas, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Tretinoin gel is the first listed.
NCT00907257 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00907257 about?
NCT00907257 is a clinical study titled "A Study of Different Use Regimens Using Two Acne Treatments". A study to determine if using 2 acne products in the morning is as safe and efficacious as using one product in the morning and one product in the evening.
What is the current status of trial NCT00907257?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 247 participants. The study started on 2009-02. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00907257?
The interventions under investigation include: Tretinoin gel (DRUG), benzoyl peroxide wash (DRUG).
Who is sponsoring clinical trial NCT00907257?
This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.